Riskpilot← Back to searchSign inGet full accessMicrobial Analytics Sweden AB
ABActiveOrg 5566800347Bruksgatan 17Technical testing and analysis · NACE 7120Est. 200510-19 employees
Revenue 2024
SEK 11,2M
+10% vs 2023
EBITDA margin
9.3%
-6% vs 2023
Equity ratio
39.7%
Financial strength
Net profit 2024
SEK 406K
-33% vs 2023
| Revenue | SEK 11,2M | +10% |
| EBITDA | SEK 1M | -6% |
| Net profit | SEK 406K | -33% |
| Total assets | SEK 4,6M | +32% |
| Equity | SEK 1,8M | +20% |
| Employees | — | — |
Legal name
Microbial Analytics Sweden AB
Org number
5566800347
Legal form
Aktiebolag
NACE code
7120 · Technical testing and analysis
Founded
2 maj 2005
Share capital
SEK 100 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Mikrobiologiska laboratorietjänster i medicintekniska och miljöanknutna sammanhang.
Address
Bruksgatan 17
Email
kap@micans.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 7 493 | 6 331 | 7 328 | 7 441 | 8 167 | 10 151 | 11 161 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 966 | −399 | 400 | 271 | −249 | 69 | −84 | 277 | 1 106 | 1 038 |
| Depreciation & amort. | −528 | −500 | −429 | −293 | −0 | −9 | −0 | −0 | −12 | −166 |
| EBIT | 438 | −899 | −29 | −22 | −249 | 60 | −84 | 277 | 1 094 | 872 |
| Net financials | −38 | 36 | −21 | 11 | −6 | 1 | −6 | −1 | 26 | 33 |
| Profit before tax | 883 | 57 | 0 | 119 | −214 | 62 | −90 | 242 | 778 | 526 |
| Tax | −229 | −32 | −17 | −38 | −0 | −0 | −0 | −21 | −172 | −120 |
| Net profit | 654 | 25 | −17 | 81 | −214 | 62 | −90 | 221 | 606 | 406 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 7 974 | 4 020 | 4 064 | 3 445 | 2 298 | 2 354 | 1 910 | 2 387 | 3 481 | 4 601 |
| Equity | 2 749 | 2 074 | 856 | 937 | 723 | 784 | 695 | 915 | 1 521 | 1 827 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 4 128 | 1 768 | 3 079 | 2 508 | 1 575 | 1 569 | 1 215 | 1 437 | 1 583 | 2 018 |
| Total debt | 4 128 | 1 768 | 3 079 | 2 508 | 1 575 | 1 569 | 1 215 | 1 437 | 1 583 | 2 018 |
EBITDA margin
9.3%
This company
15.8%
Market median
-41% vs market
20152024
Equity ratio
39.7%
This company
38.2%
Market median
+4% vs market
20152024
Return on equity
22.2%
This company
18.4%
Market median
+21% vs market
20152024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
20152024
Asset turnover
2.43×
This company
1.12×
Market median
+117% vs market
20152024
Debt / equity
1.52×
This company
0.62×
Market median
-145% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LE Audit | Audit | 2021 | — | — |
LK Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2025 | — | — |
FA Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Microbial Consulting Mölnlycke AB | Company | 60.0% | 60.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Microbial Consulting Mölnlycke AB
Microbial Analytics Sweden AB Board members of Microbial Analytics Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Erik Appelgren | Audit | 0 companies |
| Lisa Karin Cecilia Rabe | Deputy Chief Executive Officer | 0 companies |
| Fredrik Andreas Bengtsson | Chief Executive Officer | 0 companies |
| Eva-Lena Lotta Hallbäck | Board of Directors | 0 companies |
| Karsten Pedersen | Chairman | 0 companies |